Latest Morning Briefing Stories
Pandemic Leads Doctors to Rethink Unnecessary Treatment
Covid-caused delays in medical treatments and surgeries are producing data for health care providers to take another look at what’s needed and what isn’t.
Why Your Dentist Might Seem Pushy
Dentists know how to maximize the profits in your mouth. But sometimes it’s outright fraud — to the tune of billions every year.
‘Kicking You When You’re Down’: Many Cancer Patients Pay Dearly for Parking
Patients often fork over payments comparable to valet rates to park while receiving care. A recent study found that some of the country’s most prestigious cancer centers charge nearly $1,700 over the course of treatment for some types of the disease.
KHN’s ‘What the Health?’: Drug Price Effort Hits a Snag
Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
Covid Testing Has Turned Into a Financial Windfall for Hospitals and Other Providers
Because there are no caps on cost, consumers and insurers often get billed hundreds of dollars for the most reliable PCR covid test. Prices are rising and they can’t fight back.
A Primary Care Physician for Every American, Science Panel Urges
It’s time to consider primary care a “common good” akin to public education and shore up the foundation of the pandemic-battered U.S. health system, report says.
Hit by Higher Prices for Gear, Doctors and Dentists Want Insurers to Pay
The costs of personal protective equipment and disinfecting offices while seeing fewer patients have some doctors and dentists demanding that insurance companies step up.
Democrats Disagree About How to Spend Potential Prescription Drug Windfall
After a year of uncharacteristically being on the same page when it comes to health care, Democratic lawmakers are at loggerheads about what to do next. Most agree the time is ripe to tackle high drug prices. But they divide over whether to take savings from that to move to a ‘Medicare for All’ insurance system, enhance the current Medicare program or strengthen benefits under the Affordable Care Act.
KHN’s ‘What the Health?’: 100 Days of Health Policy
It’s 100 days into Joe Biden’s presidency and a surprisingly large number of health policies have been announced. But health is notably absent from the administration’s $1.8 trillion spending plan for American families, making it unclear how much more will get done this year. Meanwhile, the Centers for Disease Control and Prevention loosens its mask-wearing recommendations for those who have been vaccinated, but the new rules are confusing. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Julie Appleby, who reported the latest KHN-NPR “Bill of the Month” episode.
What a Difference a Year Makes in Colorado’s Case for a Public Option Plan
Before the pandemic, Colorado was building momentum to pass what’s known as a “public option” health plan that would lower insurance premiums and force hospitals to accept lower payments. But now with hospitals and health care providers enjoying support as front-line heroes in the pandemic, state legislators have stripped the option from their bill.